Share Prices & Company Research

Market News

09 Nov 2018 | 15:03

Biotech Growth Trust returns jump 20% in first half

Biotech Growth Trust said it boosted its net asset value per share by 20% in the first half, though it still underperformed its benchmark.

This Nasdaq Biotechnology Index, measured in sterling terms, rose 23% over the same period.

'The company's strong absolute performance can be attributed to renewed investor interest in the sector,' the fund said.

'Underperformance relative to the benchmark was chiefly caused by emerging biotechnology positions, such as Puma Biotechnology and Clovis Oncology, that significantly underperformed the index.'

At 3:03pm: (LON:BIOG) Biotech Gwth share price was -10p at 710p

Story provided by StockMarketWire.com
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.